Eisai projects Leqembi® revenue to total JPY 56.5 billi

/PRNewswire/ -- BioArctic AB's (publ) (NASDAQ STOCKHOLM: BIOA B) partner Eisai today said that they expect Leqembi sales to total JPY 56.5 billion...

Related Keywords

Stockholm , Sweden , China , Japan , Swedish , Lecanemab Leqembi , Jiang Millington , Oskar Bosson , Alzheimer Network Trials Unit , National Institutes Of Health , Alzheimer Clinical Trial Consortium , National Institute On , Vp Communications , European Union , Washington University School Of Medicine , Director Corporate Communication , Social Media , New England Journal , Clinical Trial Consortium , National Institute , National Institutes , Tau Nexgen , Dominantly Inherited , Washington University School , Commercialization Agreement , Nasdaq Stockholm Large ,